INTRODUCTION
In this report, ASKCI analyzes the financialassessment and credit risk of veterinary drug industry. It will provide you with acomprehensive understanding of this industry from the following aspects: developmentscale, operating benefit, related policies and industry analysis of majorregions and provinces, etc., as well as make scientific prediction on thefuture development veterinary drug industry.
1) TheAim of this report
n To provide readers with comprehensive & in-depthunderstanding of financial situation and credit risk onChina’sveterinary drug industry;
n To understand position of the veterinary drug industryinChina;
n To get more information of the major veterinary drugproduced regions;
n To predict what future ofChina’s veterinary drug industrywill be;
n To find out the region be worth for investment and theinvestment risks of veterinary drug industry inChina;
n To reveal opportunities in Chinese veterinary drug industry.
2) Benefitfrom the report
n Obtain latest financial information of veterinary drugindustry inChina,such as enterprise scale, total asset, sale revenue, total profit and soon;
n Evaluate the status of the veterinary drug industry inChina;
n Identify key trends and opportunities inChina’s veterinary drug industry;
n Give the future prospects ofChina’s veterinary drug industry , and point out someinvestment risks it will face;
n Find out some regions where are best worth forinvestment inChina’sveterinary drug industry.
3) Deliverables
Word-format report, with around 30-50 pages;
Excel-format database of key regions and provincesof veterinarydrug industry;
4) Timeneeded
3 weeks needed
| Part | Contents |
| 1 | Overview and policy of veterinary drug industry in China |
| 1.1 | Overview of veterinary drug industry |
| 1.1.1 | Industry definition |
| 1.1.2 | Industry life cycle |
| 1.1.3 | Industry status in national economy |
| 1.2 | Policy of veterinary drug industry |
| 1.2.1 | Policy on veterinary drug industry |
| 1.2.2 | Policy on upstream and downstream industry |
| 2 | Development scale ofChina's veterinary drug industry |
| 2.1 | Industry scale analysis of veterinary drug industry in 2011-2015 |
| 2.1.1 | Enterprise scale |
| 2.1.2 | Total asset |
| 2.1.3 | Sales revenue |
| 2.1.4 | Total profit |
| 2.2 | Industry cost analysis of veterinary drug industry in 2011-2015 |
| 2.2.1 | Sale cost |
| 2.2.2 | Sales expense |
| 2.2.3 | Administration expense |
| 2.2.4 | Financial expense |
| 3 | Operating benefit analysis of veterinary drug industry |
| 3.1 | Debt paying ability analysis of veterinary drug industry in 2011-2015 |
| 3.1.1 | Debt scale |
| 3.1.2 | Debt-to-assets ratio |
| 3.2 | Profitability analysis of veterinary drug industry in 2011-2015 |
| 3.2.1 | Ratio of profits to cost |
| 3.2.2 | Gross profit to sales |
| 3.2.3 | Profit ratio of sales |
| 3.2.4 | Return on asset |
| 3.3 | Operation ability analysis veterinary drug industry in 2011-2015 |
| 3.3.1 | Total assets turnover |
| 3.3.2 | Current asset turnover |
| 3.3.3 | Receivables turnover |
| 4 | Veterinary drug industry analysis in major regions |
| 4.1 | East China |
| 4.1.1 | Company number |
| 4.1.2 | Asset and liability |
| 4.1.3 | Sale revenue |
| 4.1.4 | Total profit |
| 4.2 | Central China |
| …… | …… |
| 4.5 | South China |
| 4.8.1 | Company number |
| 4.8.2 | Asset and liability |
| 4.8.3 | Sale revenue |
| 4.8.4 | Total profit |
| 5 | Veterinary drug industry analysis in Top 5 provinces |
| 5.1 | Province A |
| 5.1.1 | Enterprise scale |
| 5.1.2 | Total asset |
| 5.1.3 | Sales revenue |
| 5.1.4 | Total profit |
| 5.1.5 | Profitability analysis |
| 5.1.6 | Operation ability analysis |
| 5.2 | Province B |
| …… | …… |
| 5.5 | Province E |
| 6 | Future forecast of veterinary drug industry in China |
| 6.1 | Investment prospects |
| 6.1.1 | Development prospect analysis |
| 6.1.2 | Industry sale revenue forecast 2016 to 2020 |
| 6.1.3 | Industry total profit forecast 2016 to 2020 |
| 6.2 | Investment risk analysis |
| 6.2.1 | Industry policy risk |
| 6.2.2 | Raw material market risk |
| 6.2.3 | Market competition risk |
| 6.2.4 | Technology risk |
| 6.3 | Investment advices |
List of Figures
Figure1.1.2-1 Industry life cycle of veterinary drug industry inChina
Figure2.1.1-1Enterprisescale distribution ofChina’sveterinary drug industry, 2015
Figure 2.1.2-1 Total asset of veterinary drug industry inChina,2011-2015
Figure2.1.3-1 Sales revenue of veterinary drug industry inChina,2011-2015
Figure2.1.4 Total profit of veterinary drug industry inChina,2011-2015
......
List of Tables
Table 1.2.1-1 Policy on veterinary drug industry inChina,2010-2016
Table 3.2.1-1 Ratioof profits to cost of veterinary drug industry inChina,2011-2015
Table 3.2.2-1 Grossprofit to sales of veterinary drug industry inChina,2011-2015
Table 3.2.3-1 Profitratio of sales of veterinary drug industry inChina, 2011-2015
......
?本報(bào)告所有內(nèi)容受法律保護(hù)，中華人民共和國(guó)涉外調(diào)查許可證：國(guó)統(tǒng)涉外證字第1454號(hào)。
本報(bào)告由中商產(chǎn)業(yè)研究院出品，報(bào)告版權(quán)歸中商產(chǎn)業(yè)研究院所有。本報(bào)告是中商產(chǎn)業(yè)研究院的研究與統(tǒng)計(jì)成果，報(bào)告為有償提供給購(gòu)買(mǎi)報(bào)告的客戶內(nèi)部使用。未獲得中商產(chǎn)業(yè)研究院書(shū)面授權(quán)，任何網(wǎng)站或媒體不得轉(zhuǎn)載或引用，否則中商產(chǎn)業(yè)研究院有權(quán)依法追究其法律責(zé)任。如需訂閱研究報(bào)告，請(qǐng)直接聯(lián)系本網(wǎng)站，以便獲得全程優(yōu)質(zhì)完善服務(wù)。
本報(bào)告目錄與內(nèi)容系中商產(chǎn)業(yè)研究院原創(chuàng)，未經(jīng)本公司事先書(shū)面許可，拒絕任何方式復(fù)制、轉(zhuǎn)載。
在此，我們誠(chéng)意向您推薦鑒別咨詢公司實(shí)力的主要方法。
中商官網(wǎng)
數(shù)據(jù)庫(kù)
前沿報(bào)告庫(kù)
立即購(gòu)買(mǎi)
專(zhuān)家咨詢
下載訂購(gòu)表
word下載
按需定制
簡(jiǎn)繁轉(zhuǎn)換
在線咨詢
